Financial Highlights as at 31 December 2025
Share Price
$0.9160
Ordinary Shares in issue with voting rights
1,129.2m
Shares in Treasury
244.7m
NAV per Share
$1.0192
Discount to NAV per Share
10.1%
Net Assets
$1,150.9m
A Unique London-Listed Investment Company, Providing Access to Debt Capital for the Life Sciences Industry
LON · BPCR
BioPharma Credit PLC
$--
-- --%
Fetching...
BioPharma Credit PLC's primary objective is to generate predictable income for shareholders over the long term.